Label: TABRADOL- cyclobenzaprine hydrochloride kit
-
Contains inactivated NDC Code(s)
NDC Code(s): 70332-106-01 - Packager: California Pharmaceuticals, LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated January 1, 2016
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Tabradol - Pharmacist Instructions page 2
- Tabradol - Label
- Tabradol - Inactive ingredient - flavor label
- Tabradol - Pharmacist instructions Page 1
- Tabradol - Principal Label
-
INGREDIENTS AND APPEARANCE
TABRADOL
cyclobenzaprine hydrochloride kitProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70332-106 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70332-106-01 1 in 1 KIT Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE, PLASTIC 125 mL Part 2 1 BOTTLE, GLASS 0.25 g Part 3 1 BOTTLE, PLASTIC 125 mL Part 1 of 3 STRUCTURED SUSPENSION VEHICLE
suspension liquidProduct Information Route of Administration ORAL Inactive Ingredients Ingredient Name Strength SORBITOL (UNII: 506T60A25R) WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) SODIUM BENZOATE (UNII: OJ245FE5EU) DIMETHYL SULFONE (UNII: 9H4PO4Z4FT) SACCHARIN SODIUM (UNII: SB8ZUX40TY) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 125 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Part 2 of 3 CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride powder, for suspensionProduct Information Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P) (CYCLOBENZAPRINE - UNII:69O5WQQ5TI) CYCLOBENZAPRINE HYDROCHLORIDE 0.25 g in 0.25 g Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 0.5 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Part 3 of 3 STRUCTURED FLAVORING VEHICLE
flavor liquidProduct Information Route of Administration ORAL Inactive Ingredients Ingredient Name Strength GLYCERIN (UNII: PDC6A3C0OX) CHERRY (UNII: BUC5I9595W) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM CITRATE (UNII: 1Q73Q2JULR) SODIUM BENZOATE (UNII: OJ245FE5EU) WATER (UNII: 059QF0KO0R) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) XANTHAN GUM (UNII: TTV12P4NEE) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 125 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Labeler - California Pharmaceuticals, LLC (021420944) Establishment Name Address ID/FEI Business Operations California Pharmaceuticals, LLC 021420944 manufacture(70332-106) , repack(70332-106)